Study Stopped
After discussing this study with the investigators, it was decided to consider it a retrospective study rather than a clinical trial. Since we could not delete this record, we chose the termination status instead.
Effect of Cystocele Repair With Trans Obturator Tape VS. Trans Obturator Tape Alone on Stress Urinary Incontinence.
The Effect of Concurrent Cystocele Repair on Transobturator Tape in Patients With Stress Urinary Incontinence - A Comparative Study
1 other identifier
interventional
98
1 country
1
Brief Summary
The goal of this interventional study is to compare the effect of Concurrent cystocele repair and trans obturator tape (TOT) and TOT alone in a sample of Iraqi Female participants with diagnosed stress urinary incontinence and cystocele. The main questions to answer are: 1-What are the effects of the tested Interventions on the outcomes measured by The Pelvic Organ Prolapse Quantification (POP-Q) System?
- 1.What are the effects of the tested Interventions on the degree of pelvic organ prolapse?
- 2.What are the effects of the tested Interventions on the frequency, severity, and effect of Stress urinary incontinence on the quality of life of the patients?
- 3.What are the effects of the tested Interventions on the impact of lower urinary tract symptoms on the quality of the patient's life?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
September 13, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedFebruary 19, 2025
February 1, 2025
1 year
September 13, 2023
February 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Degree of Pelvic organ Prolapse (POP-Q)
Assessed using the pelvic organ prolapse quantification system, in which it classified into: 1. Stage 0: No prolapse is observed 2. Stage 1: The most proximal portion of prolapse is greater than 1 cm above the level of the hymen 3. Stage 2: The most proximal portion of prolapse is found between 1 cm higher than hymen and 1cm beneath hymen 4. Stage 3: The most distal part of the prolapse extends more than 1cm beneath the hymen but no further than 2 cm 5. Stage 4: vaginal eversion has taken place or eversion to with 2cm of TVL
At baseline, and at 9 months
Frequency, severity, and effect of urine incontinence on quality of life.
Assessed using the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-SF). The score runs from "0 to 21", with higher values indicating more severe illness
At baseline, and at 9 months
Secondary Outcomes (1)
Impact of lower urinary tract symptoms including urinary incontinence on health-related quality of life.
At baseline, and after 9 months
Study Arms (2)
Group I (TOT alone)
ACTIVE COMPARATOR49 Female Patients diagnosed with Stress urinary incontinence and cystocele and offered repair by Trans obturator tape procedure
Group II (TOT+ Cystocele Repair)
EXPERIMENTAL49 Female Patients diagnosed with Stress urinary incontinence and cystocele and offered repair by Trans obturator tape procedure concurrently with cystocele repair.
Interventions
Done under Spinal anesthesia in the dorsal lithotomy position.
Done under Spinal anesthesia in the dorsal lithotomy position..
Eligibility Criteria
You may qualify if:
- Female patients.
- Pure stress and/or stress-predominant mixed urinary incontinence (MUI) associated with cystocele.
- Had not undergone a previous SUI surgery.
- BMI less than 35 kg/m2
You may not qualify if:
- Patients out of the age limit.
- Patients refused to participate in the study.
- Severe comorbid disease (heart failure HYHA class II and above, etc.).
- Patients with a previous surgical history of transvaginal mesh.
- Patients suffering detrusor overactivity.
- Patients diagnosed with the female genital system or urinary bladder Malignancies.
- Patients diagnosed with the presence of neurological disorders that caused voiding dysfunction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Al-Mustafa University Collegelead
- Al-Sadr Teaching Hospitalcollaborator
Study Sites (1)
Al-Sadr Teaching Hospital
Amarah, Maysan Governorate, 62001, Iraq
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hayder Adnan Fawzi, Ph.D
Al-Mustafa University College
- PRINCIPAL INVESTIGATOR
Thaer Saleh Sabor Al-Omary, Ph.D
Al-Sadr Teaching Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Prof.
Study Record Dates
First Submitted
September 13, 2023
First Posted
September 21, 2023
Study Start
September 1, 2021
Primary Completion
September 1, 2022
Study Completion
September 1, 2022
Last Updated
February 19, 2025
Record last verified: 2025-02